Paul Pelckmans

Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings

Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice

Effect of adrenergic and nitrergic blockade on experimental ileus in rats

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro

Involvement of nitric oxide in the inhibitory innervation of the human isolated colon

Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture